“Winning regulatory approval and successfully launching a drug or device requires excellence at every stage of product development – from concept to commercialization. Communicating a clear, cohesive narrative across stakeholders is an underpinning of the entire process."Contact Eric
Eric brings a unique perspective to 3D clients from his more than 15 years in virtually every function of the pharmaceutical industry – from R&D and regulatory affairs to medical affairs, market access, and product launch and commercialization. He leverages this rich experience to help clients develop clear, credible, scientific communications designed to achieve regulatory, market access, and commercial success.
Eric starts each project by gaining a deep understanding of the disease state, unmet medical need, and competitive landscape. He then works with clients to identify their specific business and communications goals and helps them clearly convey the science in a way that is relevant and meaningful to each audience.
As both an executive in pharma, and a scientific and commercial consultant, Eric has garnered FDA approvals and has successfully commercialized novel therapies. He has substantial experience with the design of clinical trials, regulatory strategy and compliance, product reimbursement, and product launches. Eric has authored more than 35 peer-reviewed posters, manuscripts, and presentations. Eric earned his doctorate in Cellular and Molecular Biology from the University of Wisconsin – Madison Medical School.
Eric enjoys spending time with his spouse, two daughters, and son. He is an avid runner and leads a community running group. In his spare time, Eric enjoys traveling, skiing, and golfing and is an active supporter of independent journalism.